Athena Heart [310] -

It is intended to reduce the risk of hospitalization for AF. 3. Safety and Contraindications

: Classified as Category X ; it may cause fetal harm and should not be used by pregnant women. Drug Interactions : ATHENA HEART [310]

Clinicians should monitor several factors to prevent adverse outcomes: It is intended to reduce the risk of hospitalization for AF

The ATHENA trial was a landmark study that evaluated the efficacy of dronedarone in reducing cardiovascular hospitalizations or death. ATHENA HEART [310]

One tablet should be taken with the and one with the evening meal to ensure proper absorption. Target Population :

Monitor closely if the patient is also taking warfarin, as dronedarone can increase warfarin exposure. 4. Patient Monitoring

: Conduct regular ECGs to monitor for potential proarrhythmic effects or excessive QT prolongation.